Ken Griffin Immucell Corp Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Immucell Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 23,746 shares of ICCC stock, worth $86,672. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,746Holding current value
$86,672% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding ICCC
# of Institutions
29Shares Held
1.15MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA226KShares$823,4210.0% of portfolio
-
Cresset Asset Management, LLC Chicago, IL207KShares$756,3230.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny126KShares$458,3990.0% of portfolio
-
Bleichroeder LP New York, NY102KShares$370,8180.18% of portfolio
-
Morgan Stanley New York, NY66.8KShares$243,8780.0% of portfolio
About IMMUCELL CORP
- Ticker ICCC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,746,860
- Market Cap $28.3M
- Description
- ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...